Researchers have examined the adverse consequences of zafirlukast in Grown ups and children aged twelve or older. Occasional reports of eosinophilia accompanied by vasculitis in patients on zafirlukast have emerged. Zafirlukast is extensively hepatically metabolized by an enzyme termed CYP2C9. Zafirlukast inhibits the motion of CYP3A4, resulting in drug-drug interactions https://fsg6780124.bleepblogs.com/34861351/an-unbiased-view-of-af-dx-384-free-base